GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyundai Bioscience Co Ltd (XKRX:048410) » Definitions » Cyclically Adjusted PB Ratio

Hyundai Bioscience Co (XKRX:048410) Cyclically Adjusted PB Ratio : 8.49 (As of Jun. 04, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Hyundai Bioscience Co Cyclically Adjusted PB Ratio?

As of today (2025-06-04), Hyundai Bioscience Co's current share price is ₩11010.00. Hyundai Bioscience Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₩1,296.90. Hyundai Bioscience Co's Cyclically Adjusted PB Ratio for today is 8.49.

The historical rank and industry rank for Hyundai Bioscience Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:048410' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.03   Med: 10.79   Max: 47.42
Current: 8.53

During the past years, Hyundai Bioscience Co's highest Cyclically Adjusted PB Ratio was 47.42. The lowest was 0.03. And the median was 10.79.

XKRX:048410's Cyclically Adjusted PB Ratio is ranked worse than
87.39% of 674 companies
in the Biotechnology industry
Industry Median: 1.475 vs XKRX:048410: 8.53

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Hyundai Bioscience Co's adjusted book value per share data for the three months ended in Mar. 2025 was ₩2,447.659. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩1,296.90 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hyundai Bioscience Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Hyundai Bioscience Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Bioscience Co Cyclically Adjusted PB Ratio Chart

Hyundai Bioscience Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.32 23.26 23.03 20.56 11.36

Hyundai Bioscience Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.27 14.14 14.56 11.36 8.39

Competitive Comparison of Hyundai Bioscience Co's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Hyundai Bioscience Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hyundai Bioscience Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hyundai Bioscience Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hyundai Bioscience Co's Cyclically Adjusted PB Ratio falls into.


;
;

Hyundai Bioscience Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Hyundai Bioscience Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=11010.00/1296.90
=8.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hyundai Bioscience Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Hyundai Bioscience Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2447.659/122.5900*122.5900
=2,447.659

Current CPI (Mar. 2025) = 122.5900.

Hyundai Bioscience Co Quarterly Data

Book Value per Share CPI Adj_Book
201506 712.597 100.051 873.130
201509 741.958 100.111 908.560
201512 764.462 100.220 935.093
201603 768.838 100.561 937.261
201606 772.808 100.791 939.953
201609 737.572 101.461 891.168
201612 565.914 101.561 683.089
201703 530.181 102.851 631.935
201706 665.947 102.611 795.609
201709 827.096 103.491 979.739
201712 892.670 102.991 1,062.546
201803 888.994 104.101 1,046.887
201806 898.070 104.130 1,057.275
201809 1,026.564 105.651 1,191.158
201812 1,130.188 104.351 1,327.732
201903 1,203.191 104.491 1,411.598
201906 1,211.488 104.881 1,416.047
201909 1,300.501 105.200 1,515.475
201912 1,297.588 105.121 1,513.217
202003 1,399.122 105.354 1,628.016
202006 1,399.944 105.112 1,632.729
202009 1,540.257 106.198 1,778.007
202012 1,371.711 105.765 1,589.916
202103 1,329.359 107.357 1,517.980
202106 1,332.982 107.579 1,518.985
202109 1,678.025 108.759 1,891.418
202112 1,499.167 109.676 1,675.683
202203 1,615.374 111.848 1,770.516
202206 1,498.713 114.072 1,610.621
202209 1,635.196 114.715 1,747.445
202212 1,381.393 115.179 1,470.274
202303 1,348.919 116.507 1,419.343
202306 1,305.680 117.182 1,365.937
202309 1,261.967 118.964 1,300.436
202312 1,070.439 118.837 1,104.244
202403 1,097.105 120.123 1,119.635
202406 1,152.561 120.007 1,177.365
202409 1,033.955 120.861 1,048.745
202412 932.262 121.135 943.458
202503 2,447.659 122.590 2,447.659

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hyundai Bioscience Co  (XKRX:048410) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Hyundai Bioscience Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Hyundai Bioscience Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyundai Bioscience Co Business Description

Traded in Other Exchanges
N/A
Address
150 North-Ahyun Road, 3rd Floor Academic Cooperation Building, Ehwa Women’s University, Seodaemun-gu, Seoul, KOR
Hyundai Bioscience Co Ltd is a Korean biotechnology company. The company is engaged in developing and commercializing bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body. It has developed Vitabrid CG, a biomaterial that binds vitamin C with bio-friendly mineral layers, which is a beneficial ingredient in skin brightening, anti-aging, and anti-inflammation; and Vitabrid C12, a premium skincare brand.

Hyundai Bioscience Co Headlines

No Headlines